ImmuCell Corp (ICCC) - Financial and Strategic SWOT Analysis Review

ImmuCell Corp (ICCC) - Financial and Strategic SWOT Analysis Review

  • Products Id :- GDME317FSA
  • |
  • Pages: 33
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

ImmuCell Corp (ICCC)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


ImmuCell Corp (Immucell) is an animal health biotechnology company. It develops, manufactures and markets products that improve animal health and productivity in the dairy and beef industries. The company focuses on the prevention, diagnosis and treatment of bovine diseases. The company's major products include First Defense bovine coronavirus-escherichia coli antibody and Wipe Out dairy wipes. Immucell is also developing Mast Out, an intramammary infusion product for the treatment of subclinical mastitis in lactating dairy cows. The company develops its products based on the requirement in two areas, namely, Intelligent Mastitis Management and Calf Health. The company sells its products through distributors and dairy producers. ImmuCell is headquartered in Portland, Maine, the US.

ImmuCell Corp Key Recent Developments

May 14,2018: ImmuCell Announces Financial Results for First Quarter of 2018

Feb 08,2018: ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2017

Jan 30,2018: ImmuCell Appoints Two New Members to its Board of Directors

Aug 14,2017: ImmuCell Announces Financial Results for Second Quarter of 2017

Mar 08,2017: Bobbi Jo Brockmann is appointed to Board of Directors of ImmuCell

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

ImmuCell Corp-Key Facts 5

ImmuCell Corp-Key Employees 6

ImmuCell Corp-Key Employee Biographies 7

ImmuCell Corp-Major Products and Services 8

ImmuCell Corp-History 9

ImmuCell Corp-Locations And Subsidiaries 10

Head Office 10

Section 2-Company Analysis 11

Company Overview 11

ImmuCell Corp-Business Description 12

ImmuCell Corp-SWOT Analysis 13

SWOT Analysis-Overview 13

ImmuCell Corp-Strengths 13

ImmuCell Corp-Weaknesses 14

ImmuCell Corp-Opportunities 15

ImmuCell Corp-Threats 16

ImmuCell Corp-Key Competitors 17

Section 3-Company Financial Ratios 18

Financial Ratios-Capital Market Ratios 18

Financial Ratios-Annual Ratios 19

Performance Chart 22

Financial Performance 22

Financial Ratios-Interim Ratios 23

Financial Ratios-Ratio Charts 24

Section 4-Company's Recent Developments 25

May 14, 2018: ImmuCell Announces Financial Results for First Quarter of 2018 25

Feb 08, 2018: ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2017 27

Section 5-Appendix 29

Methodology 29

Ratio Definitions 29

About GlobalData 33

Contact Us 33

Disclaimer 33

List of Figures

ImmuCell Corp, Performance Chart (2013-2017) 22

ImmuCell Corp, Ratio Charts 24

List of Tables

ImmuCell Corp, Key Facts 5

ImmuCell Corp, Key Employees 6

ImmuCell Corp, Key Employee Biographies 7

ImmuCell Corp, Major Products and Services 8

ImmuCell Corp, History 9

ImmuCell Corp, Key Competitors 17

ImmuCell Corp, Ratios based on current share price 18

ImmuCell Corp, Annual Ratios 19

ImmuCell Corp, Annual Ratios (Cont...1) 20

ImmuCell Corp, Annual Ratios (Cont...2) 21

ImmuCell Corp, Interim Ratios 23

Currency Codes 29

Capital Market Ratios 29

Equity Ratios 30

Profitability Ratios 30

Cost Ratios 31

Liquidity Ratios 31

Leverage Ratios 32

Efficiency Ratios 32

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Zoetis Inc.

Idexx Laboratories Inc

Elanco Animal Health Inc

Merck Animal Health

Boehringer Ingelheim Animal Health Gmbh

ImmuCell Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8990
Site License
USD 250 INR 17980
Corporate User License
USD 375 INR 26970



I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]